Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Keio University To Research iPS Cells Of Alzheimer's Disease Patients

This article was originally published in PharmAsia News

Executive Summary

Keio University announced May 27 that it will start producing induced pluripotent stem cells from skin cells provided by patients with nervous system diseases such as Alzheimer's. The university will conduct research on the iPS cells in hopes of discovering the causes for the diseases and developing new therapeutic drugs. The team is also considering providing the iPS cells to other research facilities and companies to aid their new drug discovery effort. Besides AD, 25 other diseases are included in the research, such as Parkinson's disease, amyotrophic lateral sclerosis and retinal degeneration. (Click here for more - Japanese language

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts